aTyr Pharma, Inc. (ATYR) Tops Q1 EPS by 2c

aTyr Pharma, Inc. (NASDAQ: ATYR) reported Q1 EPS of ($0.17), $0.02 better than the analyst estimate of ($0.19).

For earnings history and earnings-related data on aTyr Pharma, Inc. (ATYR) click here.

You May Also Be Interested In

• VNET Group (VNET) Misses Q2 EPS by 164c
• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Tesla to launch Cybercab in Austin this month - report